Uwagawa
Sadamu Uwagawa, Koka-Gun JP
Patent application number | Description | Published |
---|---|---|
20090134358 | CURING RESIN COMPOSITION, SEALING MATERIAL FOR LIQUID CRYSTAL DISPLAY DEVICE AND LIQUID CRYSTAL DISPLAY DEVICE - It is the object of the invention to provide a curable resin composition which causes no liquid crystal contamination, which are excellent in the adhesive property to a glass, and which causes no cell gap inequality in the case it is used as a sealant for a liquid crystal display element to produce a liquid crystal display element by a one drop fill process, a sealant for a liquid crystal display element, and a liquid crystal display element. | 05-28-2009 |
Sadamu Uwagawa, Mishima-Gun JP
Patent application number | Description | Published |
---|---|---|
20090093562 | CURING RESIN COMPOSITION, SEALING MATERIAL FOR LIQUID CRYSTAL DISPLAY DEVICE AND LIQUID CRYSTAL DISPLAY DEVICE - It is the object of the invention to provide a curable resin composition which causes no liquid crystal contamination, which are excellent in the adhesive property to a glass, and which causes no cell gap inequality in the case it is used as a sealant for a liquid crystal display element to produce a liquid crystal display element by a one drop fill process, a sealant for a liquid crystal display element, and a liquid crystal display element. | 04-09-2009 |
Satoshi Uwagawa, Tokyo JP
Patent application number | Description | Published |
---|---|---|
20140049615 | LENS PROTECTION DEVICE, LENS UNIT AND IMAGE CAPTURE DEVICE - Provided is a lens protection device including one lens protection cover configured to be disposed in front of two surfaces of two image capture lenses that have the two surfaces directed in a same direction and arranged in a transverse row and to be movable between a covering position for covering the two surfaces from an outside and a retreat position for exposing the two surfaces to the outside. | 02-20-2014 |
Takashi Uwagawa, Tokyo JP
Patent application number | Description | Published |
---|---|---|
20100015249 | Antitumor agent containing 6'-amidino-2'-naphthyl 4-guanidinobenzoate or salt thereof - It is an object of the present invention to provide novel antitumor agents which have a high therapeutic index while causing neither serious adverse effects nor drug resistance, both of which are the problems associated with existing antitumor agents. In particular, it is an object of the present invention to provide novel agents and therapies which are effective for pancreas cancer, for which no effective therapies and chemotherapeutic agents exist at this stage, and are also capable of inhibiting cancer metastasis and cancer filtration. The antitumor agents, more specifically the therapeutic agents for pancreas cancer and the cancer metastasis inhibitors, of the present invention contain as an active ingredient 6′-amidino-2′-naphthyl 4-guanidinobenzoate or a salt thereof or more specifically the mesylate thereof known as nafamostat mesilate (generic name; also referred to as “Futhan,” “FUT,” and “FUT175.”). Moreover, in another mode of the present invention, the above mentioned FUT is administered in combination with existing anticancer/antitumor agents, particularly preferably in combination with gemcitabine hydrochloride. | 01-21-2010 |